Fred Alger Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Fred Alger Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $794,239 - $3.83 Million	-103,148 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $2.73 Million - $3.83 Million	103,148 New	103,148 $3.51 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $569,400 - $756,080	-13,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $333,450 - $585,270	9,000 Added 225.0%	13,000 $776,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $470,820 - $971,600	-14,000 Reduced 77.78%	4,000 $165,000
Q4 2019 Feb 14, 2020	BUY	$31.7 - $69.93 $570,600 - $1.26 Million	18,000 New	18,000 $1.12 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.